EMPAVELI® (pegcetacoplan)
www.empaveli.com
www.empaveli.com
EMPAVELI® (pegcetacoplan) is a prescription medicine used to treat adults with a disease called paroxysmal nocturnal hemoglobinuria (PNH). EMPAVELI® is the first FDA-approved PNH medication that controls both intravascular hemolysis (IVH) and extravascular hemolysis (EVH). Empaveli® is also now approved for the treatment of adult and pediatric patients aged 12 years and older with C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN), to reduce proteinuria.
Resources
PANTHERx Rare Contact
-
866-258-1895
